IGF1 and attention deficit-hyperactivity disorder: These findings suggest that IGF1 may influence GABAergic neural development, potentially contributing to the symptomatic derangements observed in human neurological disorders, particularly neurodevelopmental disorders such as ASD and attention‐deficit/hyperactivity disorder (ADHD).